These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25141276)

  • 1. Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children.
    Co MD; Terajima M; Thomas SJ; Jarman RG; Rungrojcharoenkit K; Fernandez S; Yoon IK; Buddhari D; Cruz J; Ennis FA
    Viral Immunol; 2014 Oct; 27(8):375-82. PubMed ID: 25141276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children.
    Terajima M; Co MD; Cruz J; Ennis FA
    J Infect Dis; 2015 Oct; 212(7):1052-60. PubMed ID: 25795791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.
    Jegaskanda S; Laurie KL; Amarasena TH; Winnall WR; Kramski M; De Rose R; Barr IG; Brooks AG; Reading PC; Kent SJ
    J Infect Dis; 2013 Oct; 208(7):1051-61. PubMed ID: 23812238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system.
    Friel D; Co M; Ollinger T; Salaun B; Schuind A; Li P; Walravens K; Ennis FA; Vaughn DW
    Influenza Other Respir Viruses; 2021 Jan; 15(1):110-120. PubMed ID: 32889792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy.
    Morrison BJ; Roman JA; Luke TC; Nagabhushana N; Raviprakash K; Williams M; Sun P
    J Virol Methods; 2017 Oct; 248():7-18. PubMed ID: 28624584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.
    Jegaskanda S; Co MDT; Cruz J; Subbarao K; Ennis FA; Terajima M
    J Infect Dis; 2017 Mar; 215(5):818-823. PubMed ID: 28011910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.
    Jegaskanda S; Luke C; Hickman HD; Sangster MY; Wieland-Alter WF; McBride JM; Yewdell JW; Wright PF; Treanor J; Rosenberger CM; Subbarao K
    J Infect Dis; 2016 Sep; 214(6):945-52. PubMed ID: 27354365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
    Jegaskanda S; Vandenberg K; Laurie KL; Loh L; Kramski M; Winnall WR; Kedzierska K; Rockman S; Kent SJ
    J Infect Dis; 2014 Dec; 210(11):1811-22. PubMed ID: 24916185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.
    Park JK; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Rosas LA; Cervantes-Medina A; Taubenberger JK; Memoli MJ
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults.
    Vanderven HA; Jegaskanda S; Wines BD; Hogarth PM; Carmuglia S; Rockman S; Chung AW; Kent SJ
    J Infect Dis; 2017 Dec; 217(1):12-23. PubMed ID: 29106590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.
    Memoli MJ; Shaw PA; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Fargis S; Risos K; Powers JH; Davey RT; Taubenberger JK
    mBio; 2016 Apr; 7(2):e00417-16. PubMed ID: 27094330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
    Petrie JG; Parkhouse K; Ohmit SE; Malosh RE; Monto AS; Hensley SE
    J Infect Dis; 2016 Dec; 214(12):1947-1951. PubMed ID: 27923954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preexisting Antibody-Dependent Cellular Cytotoxicity-Activating Antibody Responses Are Stable Longitudinally and Cross-reactive Responses Are Not Boosted by Recent Influenza Exposure.
    Valkenburg SA; Zhang Y; Chan KY; Leung K; Wu JT; Poon LL
    J Infect Dis; 2016 Oct; 214(8):1159-63. PubMed ID: 27493238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.
    Jegaskanda S; Job ER; Kramski M; Laurie K; Isitman G; de Rose R; Winnall WR; Stratov I; Brooks AG; Reading PC; Kent SJ
    J Immunol; 2013 Feb; 190(4):1837-48. PubMed ID: 23319732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Virus Infection Enhances Antibody-Mediated NK Cell Functions via Type I Interferon-Dependent Pathways.
    Jegaskanda S; Vanderven HA; Tan HX; Alcantara S; Wragg KM; Parsons MS; Chung AW; Juno JA; Kent SJ
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.
    Co MD; Cruz J; Takeda A; Ennis FA; Terajima M
    Hum Vaccin Immunother; 2012 Sep; 8(9):1218-22. PubMed ID: 22894961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza virus A(H1N1)2009 antibody-dependent cellular cytotoxicity in young children prior to the H1N1 pandemic.
    Mesman AW; Westerhuis BM; Ten Hulscher HI; Jacobi RH; de Bruin E; van Beek J; Buisman AM; Koopmans MP; van Binnendijk RS
    J Gen Virol; 2016 Sep; 97(9):2157-2165. PubMed ID: 27412007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.